Volume 144, Issue 4, Pages (October 2013)

Slides:

Advertisements

Similar presentations

Young Woman With Abdominal Pain David Jones, MD Annals of Emergency Medicine Volume 64, Issue 4, (October 2014) DOI: /j.annemergmed

Advertisements

Intrapulmonary Satellite Nodule of Lung Cancer as a T Factor

Volume 96, Issue 5, Pages (November 1989)

Volume 145, Issue 6, Pages (June 2014)

Tell-tale Telangiectasias

Chest X-ray Screening Improves Outcome in Lung Cancer

Colloquium on Therapy of Right Heart Failure

Environmental Causes of Cancer of the Lung Other Than Tobacco Smoke

Volume 112, Issue 4, Pages (October 1997)

When to Be Rash About a Fever and Headache

Right-Sided Chest Pain with Progressive Dyspnea

Volume 56, Issue 1, Pages (July 1969)

Epidemiology and Treatment of Lung Cancer in Seattle

Bovine Tuberculosis Eradication

Volume 105, Issue 3, Pages (March 1994)

Robert Pickering, M.D, Fernando J. Martinez, M.D CHEST

Risk of Asthma Among Finnish Patients With Occupational Rhinitis

Volume 95, Issue 1, Pages (January 1989)

Hyperbaric Oxygenation in Cardiac and Pulmonary Disease

Volume 102, Issue 6, Pages (December 1992)

Air Pollution and Chest Disease

Navin K. Jain, MD, Thiam H. Lie, MD, FCCP CHEST

Fever, Skin Eruption, Low Serum Gammaglobulin in a Child with Leukemia

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Volume 131, Issue 4, Pages (April 2007)

A 51-Year-Old Woman With an Increasing Chest Wall Mass Years After Resection of an Early Stage Lung Cancer Ajay Dhakal, MBBS, Hongbin Chen, MD, PhD,

Treatment of Malignant Pleural Effusion

The Lung Cancer Stage Page

Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? Atsushi Watanabe, MD, PhD, Tetsuya Higami, MD, PhD, Syunsuke Ohori,

Diagnostic Surgical Pathology in Lung Cancer

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,

Precision Medicine Urgency

Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer Xizhao Sui, MD, Wei Jiang, MD, Haiqing Chen, MD, Fan.

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Details and Difficulties Regarding the New Lung Cancer Staging System

Airway Stenting for Patients With Benign Airway Disease and the Food and Drug Administration Advisory Lund Mark E. , MD, FCCP, Force Seth , MD, FCCP

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer Kyong-Ah Yoon,

Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma Takahiro Mimae,

Tako-Tsubo Cardiomyopathy: Response

Weekday and Survival After Pulmonary Resections for Lung Cancer

Counterpoint: Should All ICU Patients Receive Continuous Sedation? No

Situs Inversus Totalis and Lung Cancer

Epidemic of Lung Cancer in Patients With HIV Infection

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Imaging for the Management of Community-Acquired Pneumonia

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

Propensity score–matched analysis of adjuvant chemotherapy for stage I non–small cell lung cancer Yasuhiro Tsutani, MD, PhD, Yoshihiro Miyata, MD, PhD,

The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma Yasuhiro Tsutani, MD, PhD, Yoshihiro.

Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer Masahiko Harada,

The Applicability of the Proposed IASLC Staging Revisions to Small Cell Lung Cancer (SCLC) with Comparison to the Current UICC 6th TNM Edition Sai-Hong.

Tako-Tsubo Cardiomyopathy: Response

Volume 155, Issue 1, Pages (January 2019)

Clinicopathological Characteristics of Screen-Detected Lung Cancers

Volume 92, Issue 1, Pages (July 1987)

Bedside Calibration Of Pulmonary Artery Catheters

Invasive Pulmonary Aspergillosis

Do CIs Give You Confidence?

It’s All in the “Swerve of the Curve”

Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases Kanji Nagai, MD, Yasunori Sohara, MD, Ryosuke Tsuchiya, MD,

Pulmonary Resection for Metastases from Colorectal Cancer

Volume 42, Issue 2, Pages (August 1962)

Calcification of the Coronary Artery

Volume 143, Issue 6, Pages (June 2013)

Thoracic Surgery Survey on Lung Cancer Management

Outcome of Multimodality Treatment for 188 Cases of Type B3 Thymoma

Alcoholic Cardiomyopathy and Ventricular Arrhythmias

The Clinical Impact of Solid and Micropapillary Patterns in Resected Lung Adenocarcinoma Naoki Yanagawa, MD, PhD, Satoshi Shiono, MD, PhD, Masami Abiko,

New Members of the Editorial Board

John Reid, MD, Donald Cockcroft, MD CHEST

Presentation transcript:

Volume 144, Issue 4, Pages 1238-1244 (October 2013) Risk Factors for Recurrence After Lung Cancer Resection as Estimated Using the Survival Tree Method Shigeki Sawada, MD, PhD, Natsumi Yamashita, MD, PhD, Hiroshi Suehisa, MD, PhD, Motohiro Yamashita, MD, PhD CHEST Volume 144, Issue 4, Pages 1238-1244 (October 2013) DOI: 10.1378/chest.12-3034 Copyright © 2013 The American College of Chest Physicians Terms and Conditions

Figure 1 Recurrence-free survival curve classified according to the TNM stage. CHEST 2013 144, 1238-1244DOI: (10.1378/chest.12-3034) Copyright © 2013 The American College of Chest Physicians Terms and Conditions

Figure 2 Estimated hazard rates for recurrence classified according to the TNM stage. CHEST 2013 144, 1238-1244DOI: (10.1378/chest.12-3034) Copyright © 2013 The American College of Chest Physicians Terms and Conditions

Figure 3 Survival tree. ly = lymphatic vessel invasion; p = pathologic; Pt. No. = patient number; v = blood vessel invasion. CHEST 2013 144, 1238-1244DOI: (10.1378/chest.12-3034) Copyright © 2013 The American College of Chest Physicians Terms and Conditions

Figure 4 Recurrence-free survival curves classified according to the six groups identified using the survival tree method. CHEST 2013 144, 1238-1244DOI: (10.1378/chest.12-3034) Copyright © 2013 The American College of Chest Physicians Terms and Conditions

Figure 5 Estimated hazard rates for recurrence classified according to the low-, moderate-, and high-risk groups. CHEST 2013 144, 1238-1244DOI: (10.1378/chest.12-3034) Copyright © 2013 The American College of Chest Physicians Terms and Conditions

Figure 6 Estimated hazard rates for the development of metachronous lung cancer. CHEST 2013 144, 1238-1244DOI: (10.1378/chest.12-3034) Copyright © 2013 The American College of Chest Physicians Terms and Conditions